Skip to main content

Structural brain network measures in elderly patients with cerebral small vessel disease and depressive symptoms



To investigate the relationship between diffusion tensor imaging (DTI) indicators and cerebral small vessel disease (CSVD) with depressive states, and to explore the underlying mechanisms of white matter damage in CSVD with depression.


A total of 115 elderly subjects were consecutively recruited from the neurology clinic, including 36 CSVD patients with depressive state (CSVD+D), 34 CSVD patients without depressive state (CSVD-D), and 45 controls. A detailed neuropsychological assessment and multimodal magnetic resonance imaging (MRI) were performed. Based on tract-based spatial statistics (TBSS) analysis and structural network analysis, differences between groups were compared, including white matter fiber indicators (fractional anisotropy and mean diffusivity) and structural brain network indicators (global efficiency, local efficiency and network strength), in order to explore the differences and correlations of DTI parameters among the three groups.


There were no significant differences in terms of CSVD burden scores and conventional imaging findings between the CSVD-D and CSVD+D groups. Group differences were found in DTI indicators (p <  0.05), after adjusting for age, gender, education level, and vascular risk factors (VRF), there were significant correlations between TBSS analysis indicators and depression, including: fractional anisotropy (FA) (r = − 0.291, p <  0.05), mean diffusivity (MD) (r = 0.297, p < 0.05), at the same time, between structural network indicators and depression also show significant correlations, including: local efficiency (ELocal) (r = − 0.278, p < 0.01) and network strength (r = − 0.403, p < 0.001).


Changes in FA, MD values and structural network indicators in DTI parameters can predict the depressive state of CSVD to a certain extent, providing a more direct structural basis for the hypothesis of abnormal neural circuits in the pathogenesis of vascular-related depression. In addition, abnormal white matter alterations in subcortical neural circuits probably affect the microstructural function of brain connections, which may be a mechanism for the concomitant depressive symptoms in CSVD patients.

Peer Review reports


With the gradual increase in the number of elderly people in China, cardiovascular and cerebrovascular diseases are frequent, and the incidence of cerebral small vessel disease (CSVD) is also on the rise. CSVD is a highly prevalent age-related disease. In China, lacunar infarction (LI) caused by CSVD accounts for 25 to 50% of ischemic stroke, which is higher than the occurrence in Western countries [1]. The prevalence of white matter hyperintensity increases from 50 to 95% between the ages of 50 and 80 [2],cerebral microbleeds are 24% [3], and enlarged perivascular space (EPVS) is as high as 79.9% [4]. CSVD is an important cause of vascular-related depression [5, 6]. Given that the underlying pathogenesis remains controversial [7], multimodal neuroimaging is usually used to detect lesions that lead to CSVD. There are many recognized CSVD structural markers on MRI [8], including WMH, LI, CMBs, and EPVS. These features of CSVD imaging are interrelated, and their correlation with depression has been indicated [9, 10].

With the continuous development of multimodal neuroimaging technology, the understanding of brain information processing tends to create a new approach to the interconnected holistic brain network analysis. Currently, many studies have shown that brain network connections in CSVD patients are disrupted [11,12,13], and the diffusion tensor imaging (DTI) is a method used to study white matter fiber disconnection damage and explore damage to structural connections of brain regions [14]. White matter microstructural damage caused by CSVD destroys the integrity of white matter fibers and damages the nerve fiber network, resulting in symptoms such as psychomotor retardation, hypomotility, low mood, and cognitive decline [15]. The damage of the brain white matter microstructure caused by CSVD is related to psychomotor retardation, hypomotility, low mood, and cognitive decline [15]. However, whether these new findings can be identified in CSVD patients with depressive symptoms has not been determined.

Therefore, we aimed to explore the relationship between white matter microstructure and depression in patients with CSVD by using different DTI measurements. The main DTI parameters evaluated were fractional anisotropy (FA), mean diffusion (MD), axial diffusion (AD), and radial diffusion (RD). We chose FA and MD to represent fiber tract measurements, as they are the most commonly used indicators. By comparing tract-based spatial statistics (TBSS) analysis indicators and structural brain network measures in CSVD patients, we hope to provide some evidence for the potential mechanism of early depression in patients with CSVD. In addition, we aimed to search for more downstream neuroimaging markers in patients with CSVD-induced depression.



We recruited 115 right-handed elderly subjects from the Neurology Department of the Second Hospital of Tianjin Medical University. The inclusion criteria of CSVD patients were as follows: (1) 50 to 80 years old; (2) at least 6 years of education; (3) Meet Staals scoring criteria [16]; (4) Informed consent signed by participants. All CSVD patients underwent overall psychological function through Montreal Cognitive Assessment (MoCA). Patients were assessed for depression using the 17 item Hamilton Depression Rating Scale (HAMD-17). Patients with a HAMD-17 score of 7–17 were classified as CSVD with depressive state (CSVD+D), while those with a score below 7 were classified as CSVD without depressive state (CSVD-D) [17,18,19].

Exclusion criteria: (1) severe physical disability; (2) WMH due to non-vascular dysfunction; (3) Cognitive impairment; (4) Clinical dementia score (CDR) < 0.5; (5) MoCA score < 26; (6) No stenosis of intracranial and extracranial vascular; (7) Cardiogenic cerebral embolism; (9) Alcohol or drug abuse disorder or serious mental disorder; (10) Inability to cooperate with evaluation or MRI.

Forty-five controls (Con) were included from Tianjin, China. The inclusion criteria of NC are as follows: (1) No clinical stroke history; (2) at least 6 years of education; (3) No history of major diseases of liver, heart, lung and other important organs; (4) Fazekas grade ≤ 1 and MRI scan showed no other significant abnormalities; (5) HAMD-17 score < 8; (6) Cognitive assessment test were normal; (7) No vascular risk factors such as hypercholesterolemia, diabetes, hypertension, and smoking evidence.

During the course of the study, 3 CSVD patients were excluded for personal reasons, 2 controls and 2 CSVD patients for visible head movement during MRI. Therefore, 36 CSVD+D patients, 34 CSVD-D patients and 45 Con were included. All subjects gave written informed consent, and this study was approved by the institutional review board of the second hospital of Tianjin Medical University.

MRI acquisition

MRI scans were performed on a 3.0 T scanner (GE HealthCare, USA). T1 images parameters: TR = 8.2 ms, TE = 3.2 ms, TI = 450 ms, slice thickness = 1.0 mm, gap = 0, flip angle = 12°, FOV = 256 × 256 mm2, slice number = 166; T2 FLAIR images parameters: TE = 150 ms, TR = 9075 ms, TI = 2250 ms, FOV = 256 mm2, number of slices = 160; Diffusion-weighted imaging was acquired in the anterior-to-posterior phase-encoding direction, and b-values for non-zero gradient volumes were 1000 s/mm2 along 32 gradient directions. Acquisition of each diffusion-weighted image was completed with a gradient-free image, and b-value for the reference volumes were 0. Images scanned in the opposite phase-encoding direction were also acquired to correct for distortions caused by susceptibility in the scans. The DTI sequences parameters were as follows: TR = 8000 ms, TE = 88.4 ms, matrix = 128 × 128, FOV = 256 × 256 mm, NEX = 1, slice thickness = 2 mm, gap = 0 and number of slices  =  75.

Grading and evaluation of CSVD lesions on MRI

The total burden of CSVD imaging was reflected using a well validated CSVD burden scoring scale, which is an ordinal scoring scale of 0–4 points [16]. One point when there is one or more lacunar lesions (LI) on MRI; one point when there are deep microbleeds (CMBs); one point when 3 scores on the Fazekas scale for periventricular white matter hyperintensities (WMHs) and (or) 2–3 scores on the Fazekas scale of deep WMHs; one point when the grade of enlarged perivascular space (EPVs) in basal ganglia is grade 2–3 [16]. The number of CMBs was scaled by Microbleed anatomical grading scale (MARS) [20]. Maclulich’s method was used to record and score EPVS [21]. The above scores were rated by two experienced neurologists blinded to clinical data. The CSVD burden scores and conventional imaging findings between the CSVD-D and CSVD+D groups were compared.

MRI data preprocessing analysis

Structural data

Structural images were preprocessed using the CAT12 toolbox available in the Statistical Parametric Mapping 12 package (SPM12). The following steps were used through MATLAB 2019a: normalized T1 images to template space and segmented images into gray matter, white matter, and cerebrospinal fluid; visual inspection; the total intracranial volume was evaluated; check for data homogeneity; the Gaussian kernel of full width at half maximum 6 mm (FWHM = 6 mm) was used. The “brain volume/ intracranial volume (ICV) x 100%” was used to display WMHs, gray and white matter volume [22].

DTI measures

DTI images were pre and post processed using FSL software and analyzed based on TBSS [23]. Skeleton threshold was set to less than 0.2. Global FA and MD values were computed by averaging the FA/MD values across the whole skeleton. The skeletonized FA or MD maps were entered into a voxel group level analysis. Statistical significance was assessed using the FSL permutation test. As the statistical modeling of voxel wise statistical analysis, the general linear model (GLM) was performed. Voxel-based pairwise group comparisons of CSVD-D versus CSVD+D, Con versus CSVD+D, and Con versus CSVD-D were performed using GLM. The covariates included sex, age, education, and vascular risk factors (VRF). The significance level of the two DTI parameters (FA, MD) is p<0.05 (5000 permutations, strong control of familywise error [FWE] correction for multiple comparisons correction using the threshold-free cluster enhancement) [24]. To illustrate the difference between the groups, displayed using the JHU white matter tractography atlas.

Brain network construction

Using the Pipeline of the Analyze Brain Diffusion Image Toolkit (PANDA) to preprocess the raw DTI data [25]. Using the automated anatomical labeling (AAL) 90 atlas [26]. The Fiber Assignment Continuous Tracking (FACT) algorithm was used to generate whole brain white matter fiber reconstructions. The number of streamlines is the surrogate measure of the number of fibers [27]. Streamlines terminate if the fiber is switched on at an angle > 45 ° or encounters a voxel with FA < 0.2 [28]. The structured brain network was ultimately structured by 90 for each subject 90 × 90 fiber number (FN) weighted matrix construction. Using the graph theoretic network analysis toolbox (GRETNA) [29], global topology metrics were calculated. Different rarefaction thresholds ranging from 0.1 to 0.3 at 0.01 intervals. The topological property parameters analyzed in this study include: global efficiency (EGlobal), local efficiency (ELocal), network strength and small world properties. The network strength was defined as the overall accumulation of fiber number on all nodes [30]. The regional efficiency of each node is a measure of its connectivity to all other nodes in the network [31]. Finally, a 3D brain map was visualized using the BrainNet Viewer ( [32] to intuitive display the position of damaged nodes after Bonferroni correction.

Statistical methods

Analyses were performed with SPSS version19.0 (IBM Corp., Armonk, NY, USA), baseline data were analyzed by one-way analysis of variance (ANOVA). Normally distributed measurement data are expressed as x ± s. The non-normally distributed continuous variables were expressed as median (interquartile ranges, IQR) and were compared using the Wilcoxon rank-sum test. The categorical data were expressed as numbers with percentages and comparisons between groups were performed using the χ2 test. Post hoc test was used for comparisons between groups, and Bonferroni correction was used for multiple comparisons. Partial correlation analysis was used to assess the relationship between Hamilton Depression Score and DTI measures in patients with CSVD after adjusting for age, sex, education, and VRF. Two-tailed p-value < 0.05 was considered statistically significant.


Demographic data and clinical measurements

Among the subjects (n = 115), 70 subjects were diagnosed with CSVD, of which 36 CSVD patients were diagnosed with CSVD+D group, the remaining 34 CSVD patients were CSVD-D group, and 45 subjects were Con group. The baseline data are listed in Table 1. There were no significant differences in age, gender, education and MoCA scores among the three groups (p > 0.05). There were no significant differences in VRF between the CSVD-D and CSVD+D groups (p > 0.05). The HAMD scores of CSVD+D group were the highest among the three groups, representing the most severe depression. HAMD scores were significantly lower in Con group compared to CSVD-D and CSVD+D groups.

Table 1 Demographic and clinical characteristics

Neuroimaging findings in patients with CSVD

There were no significant differences in terms of CSVD burden scores between the CSVD-D and CSVD+D groups, imaging findings, and brain volume (as a percentage of total intracranial volume), and the results are shown in Table 2. The results of group comparisons of the DTI measurement indexes are shown in Fig. 1. FA, MD, EGlobal, ELocal, and network strength showed significant differences among the three groups, further descriptive details can be found in Table 3. The values of FA, ELocal and network intensity were significantly lower in CSVD+D than those in CSVD-D and Con groups, EGlobal showed significant difference between CSVD+D and Con groups. Meanwhile, MD was significantly higher in CSVD+D than that in CSVD-D and Con groups (Bonferroni corrected, p < 0.05).

Table 2 Neuroimaging findings of CSVD patients
Fig. 1
figure 1

Group difference of DTI measures. (A–E) One-way ANOVA test was applied to conduct the group comparison of DTI measures, p-value < 0.05 was considered to be statistically significant. * represents p-value < 0.05 after Bonferroni correction. Abbreviations:CSVD−D, CSVD without depression symptoms; CSVD+D, CSVD with depression symptoms; Con, control group; FA, mean fractional anisotropy of the skeleton; MD, mean of mean diffusivity of the skeleton; Eglobal, global efficiency; Elocal, local efficiency

Table 3 DTI measures

FA and MD of whole-brain Fiber tracts

For evaluating voxel WM integrity differences between each group pair using the TBSS method to analyze DTI parameters (Fig. 2 and Fig. 3). Compared with the CSVD-D group, the CSVD+D group showed significantly decreased FA values and significantly elevated MD values in a wide range of WM tracts. Compared with the Con group, the CSVD+D group showed significantly decreased FA values and significantly increased MD values in extensive WM tracts. Meanwhile, compared with the Con group, the CSVD-D group shows significantly decreased FA values in a wide range of WM tracts. The extensive WM tracts described above included the anterior thalamic radiation, bilateral corticospinal tract, bilateral cingulate gyrus, bilateral hippocampus,forceps major, forceps minor, bilateral inferior fronto-occipital fasciculus, bilateral inferior longitudinal fasciculus, bilateral superior longitudinal fasciculus, bilateral uncinate fasciculus, and bilateral superior longitudinal fasciculus (temporal part) (FWE corrected, p < 0.05). However, there was no significant difference in MD values between CSVD-D group and Con group.

Fig. 2
figure 2

Voxel-wise Tract-Based Spatial Statistics differences in FA metrics between groups. Green represents the mean WM skeleton of all subjects. Top row: Red-yellow voxels (thickened for better visibility) represent the WM regions with decreased FA in the CSVD+D patients compared with CSVD-D subjects (FWE corrected, p < 0.05). Middlerow: Red-yellow voxels represent the WM regions with reduced FA in the CSVD+D group compared with control group (FWE corrected, p < 0.05). Bottom row: Red-yellow voxels represent the WM regions with reduced FA in the CSVD-D group compared with control group (FWE corrected, p < 0.05)

Fig. 3
figure 3

Voxel-wise Tract-Based Spatial Statistics differences in MD metrics between groups. Green represents the mean WM skeleton of all subjects. Top row: bule voxels (thickened for better visibility) represent the WM regions with increased MD in the CSVD+D patients compared with CSVD-D subjects (FWE corrected, p < 0.05). Middlerow: bule voxels represent the WM regions with increased MD in the CSVD+D group compared with control group (FWE corrected, p < 0.05). Bottom row: There are no significant WM microstructural differences between the CSVD-D patients and control subjects

Differences in structural network indicators

The Con group, CSVD-D group, and CSVD+D group showed good small world properties at all thresholds (γ > 1, λ ≈ 1, σ > 1). We analyzed the differences in the structural network of the three groups, statistically significant results by Bonferroni correction. In Fig. 4, compared with CSVD-D group, CSVD+D group had obviously damaged nodes, mainly located in the left middle frontal gyrus (p = 0.006) and the left insula (p = 0.012). In Fig. 5, compared with the Con group, the nodes with significantly impaired efficiency in the CSVD+D group were mainly located in the bilateral hippocampus (left- p = 0.036, right- p = 0.001), bilateral middle frontal gyrus (orbital part) (left- p = 0.004, right- p = 0.021), bilateral middle frontal gyrus (left- p = 0.001, right- p = 0.024), bilateral insula (left- p = 0.001, right- p = 0.019), bilateral superior frontal gyrus (dorsolateral) (left- p = 0.033, right- p = 0.006), right olfactory cortex (p = 0.007), right fusiform gyrus (p = 0.007), right superior frontal gyrus (orbital part) (p = 0.019), right amygdala (p = 0.020) and left lingual (p = 0.011). In Fig. 6, compared with the Con group, the CSVD-D group had significantly impaired nodes, mainly located in the left caudate (p = 0.008), left pallidum (p = 0.010), left middle frontal gyrus (orbital part) (p = 0.011), left superior frontal gyrus (orbital part) (p = 0.021), right amygdala (p = 0.018), right inferior frontal gyrus (orbital part) (p = 0.023) and right olfactory cortex (p = 0.027).

Fig. 4
figure 4

Regions with impaired regional efficiency in CSVD+D group relative to CSVD-D group. The regions impaired in efficiency are shown with blue nodes, with node size representing the between-group differences in regional efficiency (Bonferroni corrected, p < 0.05). Abbreviations: MFG. L represents left middle frontal gyrus, INS. L represents left Insula

Fig. 5
figure 5

Regions with impaired regional efficiency in CSVD+D group relative to control group. The regions impaired in efficiency are shown with blue nodes, with node size representing the between-group differences in regional efficiency (Bonferroni corrected, p < 0.05). Abbreviations: MFG. L and MFG. R represents bilateral middle frontal gyrus, INS. L and INS. R represents bilateral lnsula, HIP. L and HIP. R represents bilateral hippocampus, ORBmid. L and ORBmid. R represents bilateral orbital middle frontal gyrus, SFGdor. L and SFGdor. R represents bilateral dorsolateral superior frontal gyrus, OLF. R represents right olfactory cortex, FFG. R represents right fusiform gyrus, LING. L represents left lingual gyrus, AMYG. R represents right amygdala, ORBsup.R represents right superior frontal gyrus of orbit

Fig. 6
figure 6

Regions with impaired regional efficiency in CSVD-D group relative to control group. The regions impaired in efficiency are shown with blue nodes, with node size representing the between-group differences in regional efficiency (Bonferroni corrected, p < 0.05). Abbreviations: CAU. L represents left caudate nucleus, PAL. L represents left lenticular globus pallidus, ORBmid. L represents left orbital middle frontal gyrus, AMYG. R represents right amygdala, ORBsup. L represents left superior frontal gyrus of orbit, ORBinf. R represents right lnferior frontal gyrus of orbit, OLF. R represents right olfactory cortex

Correlation analysis

Partial correlation analysis was performed between DTI measures and depression scale scores after adjustment for age, gender, education and VRF. A significant correlation was found between FA and HAMD scores (r = − 0.291, p < 0.05), MD and HAMD scores (r = 0.297, p < 0.05), ELocal and HAMD scores (r = − 0.278, p < 0.01), network strength and HAMD scores (r = − 0.403, p < 0.001). However, no significant correlation was observed between EGlobal and HAMD scores (r = − 0.142, p = 0.136).


There were no significant differences in terms of CSVD burden scores and conventional imaging findings between participants in the CSVD-D and CSVD+D groups, which indicates that conventional MRI findings may not be of much significance for the discovery of patients with CSVD complicated with depression, so further analysis of advanced MRI sequences, such as DTI, is required in the follow-up. We investigated DTI sequences based on TBSS analysis methods to identify damage to white matter fibers that occurs during the disease process. The results indicated that white matter fiber tracts of CSVD patients with depression were damaged. For FA and MD, compared with participants in the Con group and the CSVD-D group, participants in the CSVD+D group showed different degrees of damage to fiber tracts in almost all parts of the brain. Correlation analysis showed that FA was negatively correlated with HAMD scores, and MD was positively correlated with HAMD scores. Notably, there was no significant difference between participants in the Con group and CSVD-D group in terms of MD, which means that in patients with CSVD and depression, while demyelination of nerve fibers occurs, the microstructural organization is also significantly damaged. FA measures the restriction of the movement of water molecules in all directions and can describe the histomorphological features of the region, and decreased FA is associated with disturbed white matter fiber homogeneity [33]. Some studies reported that MD may be more sensitive in detecting mild damage, while FA captures more severe damage [34, 35]. Long associated fibers, such as the superior longitudinal fasciculus and uncinate fasciculus, showed a significant increase in MD in the preclinical stage. These long-associated fibers are generally considered to form myelin relatively late and are vulnerable to injury and decline in later life [36,37,38]. Disruption of white matter integrity may be related to changes in the structure and density of nerve fibers, as well as decreased axonal numbers, abnormal myelin sheaths, and gliosis [39]. This change may be the neuroanatomical basis of CSVD with depression, which reflects the hypothesis of “vascular depression” to a certain extent [40]. Hence, the damaged cingulate gyrus found in this study is an important part of the emotional circuit and participates in the processes of emotion and self-evaluation, which are closely related to depressive symptoms. Some scholars have found abnormalities in cerebral blood flow and metabolism in the posterior cingulate gyrus of patients with depression, which suggests that depression may correspond to low function of the posterior cingulate gyrus [41].

The significant finding of this study is that the characteristics of the structural network are closely related to depression in patients with CSVD. Because the structural brain network represents the integrity of white matter connections, it arguably reflects the underlying mechanisms of depression in patients with CSVD more than any other measure. The structural network connectivity of participants in the CSVD-D group was significantly higher than that of participants in the CSVD+D group. The present study found that with regard to regional efficiency, participants in the Con group showed significantly higher values than participants in the CSVD+D group in several areas, including the bilateral hippocampus, bilateral middle frontal gyrus (orbital part), bilateral middle frontal gyrus, bilateral insula, bilateral superior frontal gyrus (dorsolateral), right olfactory cortex, right fusiform gyrus, right superior frontal gyrus (orbital part), right amygdala and left lingual; most of these areas are part of the limbic system. The limbic cortex includes the allogenic cortex (such as the ancient cortex of the hippocampus and dentate gyrus, the septum and the amygdala, etc.) and the intermediate cortex (including the posterior part of the orbitofrontal cortex, insula, temporal pole, cingulate gyrus, etc.,), which participate in mediating instinctual and emotional behavior [42]. At the same time, neuroanatomy has confirmed that the prefrontal lobe is the key part of emotion regulation, which is related to cognition, emotion and conscious experience. The hippocampus is mainly responsible for memory and emotional control. Studies have shown that patients with recurrent and persistent depression have a significantly smaller hippocampus in the brain. However, no changes in this feature of the depression were found in the primary stage, which means that the disease itself caused this change in the brain. However, the study also pointed out that this change is reversible because the shrinkage is mainly due to the disconnection of nerve cells rather than the death of nerve cells, as in dementia. The combination of psychological and drug therapy can promote hippocampal regrowth [43]. We also studied non-depressed CSVD patients as well as healthy controls. The results showed that DTI measurements deteriorated gradually from Con to CSVD, followed by concomitant depression.

The above TBSS analysis results were highly consistent with the results of the structural network. A study found that the fiber tracts connected to the superior frontal gyrus included the inferior fronto-occipital fasciculus (IFOF), which connects to the lingual and gyrus parahippocampal/hooked cingulum [44]. These fiber bundles were closely related to the limbic system. In the insula, white matter fibers from the terminal capsule gather together and surround the uncinate fasciculus, radiating connections to the temporal pole, the medial temporal lobe and the amygdala complex [45]. The superior longitudinal fasciculus II is related to the connection between the angular gyrus and the anterior/ middle parts of the middle frontal gyrus [46]. The study found that FA values in the right SLF were positively correlated with the severity of anxiety and depression [47]. The uncinate tract is involved in the fiber connections of the entorhinal cortex, fusiform gyrus, superior temporal gyrus, and middle temporal gyrus [48]. The olfactory forebrain is closely related to the limbic system [49], the amygdala is a subcortical structure of the limbic system. It connects with the olfactory cortex through fibers and is involved in neural circuits of fear and defensive behavior [50].

Possible mechanisms of the pathogenesis of depressive symptoms in CSVD are as follows: 1. The “vascular depression hypothesis” holds that the increased incidence of depression in patients with CSVD may be due to the destruction of the subcortical pathway connecting brain regions, namely, cerebral white matter lesions which caused by cerebrovascular diseases, damage the the prefrontal subcortical circuit. It suggests that structural damage inherently disrupts network efficiency, leading to a depressive state [40, 51]. 2. CSVD is destructive when it occurs; it disrupts the corticostriatal-pallidum-thalamocortical circuit and affects noradrenergic and serotonergic neural pathways, resulting in a decrease in the levels of these two neurotransmitters. The subsequent corresponding metabolic activities are hindered, and the inability to achieve normal physiological activities results in depression [52]. 3. Cerebral ischemia leads to oxidative stress, and free radicals can attack the brain’s nerve tissue, cause astrocyte apoptosis, interfere with the maintenance of brain tissue and repairment of nerve injury by microglia, which is also an important cause of depression-related network damage [53, 54].


This study still had some limitations. First, the sample size of our study was relatively small, although we felt that the study was sufficiently effective for the analysis performed. Second, this was a cross-sectional cohort study, and we could not draw a causal relationship between depressive states and brain structural changes, as that would require repeated measures of longitudinal data. Third, this article only included patients aged 50–80 years, and CSVD patients of other age groups with depressive states require further study with large samples. Fourth, deterministic fiber tracking has some limitations in tracking complex white matter structures, especially cross fibers, which will be overcome by more advanced white matter imaging technology.


In this study, DTI technology was applied to elderly patients with CSVD and depression. At the same time, the degree of depression was evaluated by the HAMD score, FA, and MD values; also, structural network indices in patients’ DTI parameters were effectively measured. Through data comparison and analysis, the results suggest that FA, MD and/or structural network indices change in emotion-related brain areas (the frontotemporal lobe, thalamus, cingulate gyrus and hippocampus), which revealed the integrity of brain white matter is damaged in CSVD patients with depression. The change in white matter microstructure and structural network index can reflect the degree of depression to a certain extent, providing a more direct structural basis for the hypothesis of abnormal neural circuits in the pathogenesis of vascular depression.

Availability of data and materials

The datasets generated and/or analyzed during the current study are not publicly available due to the complexity and uniqueness of the raw MRI data, as well as the limitations of laboratory policies but are available from the corresponding author on reasonable request.


  1. Tsai CF, Thomas B, Sudlow CL. Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. Neurology. 2013;81(3):264–72.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wen W, Sachdev PS, Li JJ, Chen X, Anstey KJ. White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44-48. Hum Brain Mapp. 2009;30(4):1155–67.

    Article  PubMed  Google Scholar 

  3. Pinter D, Enzinger C, Fazekas F. Cerebral small vessel disease, cognitive reserve and cognitive dysfunction. J Neurol. 2015;262(11):2411–9.

    Article  PubMed  Google Scholar 

  4. Zhang C, Chen Q, Wang Y, Zhao X, Wang C, Liu L, et al. Risk factors of dilated Virchow-Robin spaces are different in various brain regions. PLoS One. 2014;9(8):e105505.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Allan CL, Sexton CE, Kalu UG, McDermott LM, Kivimäki M, Singh-Manoux A, et al. Does the Framingham stroke risk profile predict white-matter changes in late-life depression? Int Psychogeriatr. 2012;24(4):524–31.

    Article  PubMed  Google Scholar 

  6. Bunce D, Batterham PJ, Christensen H, Mackinnon AJ. Causal associations between depression symptoms and cognition in a community-based cohort of older adults. Am J Geriatr Psychiatry. 2014;22(12):1583–91.

    Article  PubMed  Google Scholar 

  7. Rensma SP, van Sloten TT, Launer LJ, Stehouwer CDA. Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2018;90:164–73.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Brookes RL, Herbert V, Lawrence AJ, Morris RG, Markus HS. Depression in small-vessel disease relates to white matter ultrastructural damage, not disability. Neurology. 2014;83(16):1417–23.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Pasi M, Poggesi A, Salvadori E, Diciotti S, Ciolli L, Del Bene A, et al. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany study. Int J Geriatr Psychiatry. 2016;31(6):611–8.

    Article  PubMed  Google Scholar 

  11. Ter Telgte A, van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, de Leeuw FE. Cerebral small vessel disease: from a focal to a global perspective. Nat Rev Neurol. 2018;14(7):387–98.

    Article  PubMed  Google Scholar 

  12. Yi L, Wang J, Jia L, Zhao Z, Lu J, Li K, et al. Structural and functional changes in subcortical vascular mild cognitive impairment: a combined voxel-based morphometry and resting-state fMRI study. Plos One. 2012;7(9):e44758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Li M, Meng Y, Wang M, Yang S, Wu H, Zhao B, et al. Cerebral gray matter volume reduction in subcortical vascular mild cognitive impairment patients and subcortical vascular dementia patients, and its relation with cognitive deficits. Brain Behav. 2017;7(8):e00745.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lope-Piedrafita S. Diffusion tensor imaging (DTI). Methods Mol Biol (Clifton, NJ). 2018;1718:103–16.

    Article  CAS  Google Scholar 

  15. Kloppenborg RP, Nederkoorn PJ, Grool AM, Vincken KL, Mali WP, Vermeulen M, et al. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study. Neurology. 2012;79(20):2029–36.

    Article  CAS  PubMed  Google Scholar 

  16. Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228–34.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Riedel M, Möller HJ, Obermeier M, Schennach-Wolff R, Bauer M, Adli M, et al. Response and remission criteria in major depression--a validation of current practice. J Psychiatr Res. 2010;44(15):1063–8.

    Article  PubMed  Google Scholar 

  18. Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150(2):384–8.

    Article  PubMed  Google Scholar 

  19. Pavlovic AM, Pekmezovic T, Zidverc Trajkovic J, Svabic Medjedovic T, Veselinovic N, Radojicic A, et al. Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression. Int J Geriatr Psychiatry. 2016;31(1):58–65.

    Article  PubMed  Google Scholar 

  20. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jäger HR, et al. The microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73(21):1759–66.

    Article  CAS  PubMed  Google Scholar 

  21. Maclullich AM, Wardlaw JM, Ferguson KJ, Starr JM, Seckl JR, Deary IJ. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry. 2004;75(11):1519–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Huang L, Chen X, Sun W, Chen H, Ye Q, Yang D, et al. Early segmental white matter fascicle microstructural damage predicts the corresponding cognitive domain impairment in cerebral small vessel disease patients by automated Fiber quantification. Front Aging Neurosci. 2020;12:598242.

    Article  PubMed  Google Scholar 

  23. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage. 2006;31(4):1487–505.

    Article  PubMed  Google Scholar 

  24. Nichols T, Hayasaka S. Controlling the familywise error rate in functional neuroimaging: a comparative review. Stat Methods Med Res. 2003;12(5):419–46.

    Article  PubMed  Google Scholar 

  25. Cui Z, Zhong S, Xu P, He Y, Gong G. PANDA: a pipeline toolbox for analyzing brain diffusion images. Front Hum Neurosci. 2013;7:42.

    PubMed  PubMed Central  Google Scholar 

  26. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage. 2002;15(1):273–89.

    Article  CAS  PubMed  Google Scholar 

  27. Bigourdan A, Munsch F, Coupé P, Guttmann CR, Sagnier S, Renou P, et al. Early Fiber number ratio is a surrogate of corticospinal tract integrity and predicts motor recovery after stroke. Stroke. 2016;47(4):1053–9.

    Article  PubMed  Google Scholar 

  28. Taoka T, Morikawa M, Akashi T, Miyasaka T, Nakagawa H, Kiuchi K, et al. Fractional anisotropy--threshold dependence in tract-based diffusion tensor analysis: evaluation of the uncinate fasciculus in Alzheimer disease. AJNR Am J Neuroradiol. 2009;30(9):1700–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Wang J, Wang X, Xia M, Liao X, Evans A, He Y. GRETNA: a graph theoretical network analysis toolbox for imaging connectomics. Front Hum Neurosci. 2015;9:386.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Du J, Wang Y, Zhi N, Geng J, Cao W, Yu L, et al. Structural brain network measures are superior to vascular burden scores in predicting early cognitive impairment in post stroke patients with small vessel disease. NeuroImage Clinical. 2019;22:101712.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Achard S, Bullmore E. Efficiency and cost of economical brain functional networks. PLoS Comput Biol. 2007;3(2):e17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Xia M, Wang J, He Y. BrainNet viewer: a network visualization tool for human brain connectomics. Plos One. 2013;8(7):e68910.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Grieve SM, Williams LM, Paul RH, Clark CR, Gordon E. Cognitive aging, executive function, and fractional anisotropy: a diffusion tensor MR imaging study. AJNR Am J Neuroradiol. 2007;28(2):226–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Cubon VA, Putukian M, Boyer C, Dettwiler A. A diffusion tensor imaging study on the white matter skeleton in individuals with sports-related concussion. J Neurotrauma. 2011;28(2):189–201.

    Article  PubMed  PubMed Central  Google Scholar 

  35. O'Dwyer L, Lamberton F, Bokde AL, Ewers M, Faluyi YO, Tanner C, et al. Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer's disease. PLoS One. 2011;6(6):e21745.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Bender AR, Völkle MC, Raz N. Differential aging of cerebral white matter in middle-aged and older adults: a seven-year follow-up. NeuroImage. 2016;125:74–83.

    Article  PubMed  Google Scholar 

  37. Nassir C, Ghazali MM, Safri AA, Jaffer U, Abdullah WZ, Idris NS, et al. Elevated circulating microparticle subpopulations in incidental cerebral white matter Hyperintensities: a multimodal study. Brain Sci. 2021;11(2):133.

    Article  CAS  PubMed  Google Scholar 

  38. Petersen M, Frey BM, Mayer C, Kühn S, Gallinat J, Hanning U, et al. Fixel based analysis of white matter alterations in early stage cerebral small vessel disease. Sci Rep. 2022;12(1):1581.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Takeda M, Tanaka T, Kudo T. Elderly depression and diffusion tensor imaging. Psychogeriatrics. 2011;11(1):1–5.

    Article  PubMed  Google Scholar 

  40. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry. 1997;54(10):915–22.

    Article  CAS  PubMed  Google Scholar 

  41. Martin SD, Martin E, Rai SS, Richardson MA, Royall R. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry. 2001;58(7):641–8.

    Article  CAS  PubMed  Google Scholar 

  42. Murray I, Bhanot G, Bhargava A. Neuron-glia-immune triad and Cortico-limbic system in pathology of pain. Cells. 2021;10(6):1553.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Hermens DF, Hatton SN, Lee RSC, Naismith SL, Duffy SL, Paul Amminger G, et al. In vivo imaging of oxidative stress and fronto-limbic white matter integrity in young adults with mood disorders. Eur Arch Psychiatry Clin Neurosci. 2018;268(2):145–56.

    Article  PubMed  Google Scholar 

  44. Briggs RG, Khan AB, Chakraborty AR, Abraham CJ, Anderson CD, Karas PJ, et al. Anatomy and white matter connections of the superior frontal gyrus. Clin Anat (New York, NY). 2020;33(6):823–32.

    Article  Google Scholar 

  45. Nachtergaele P, Radwan A, Swinnen S, Decramer T, Uytterhoeven M, Sunaert S, et al. The temporoinsular projection system: an anatomical study. J Neurosurg. 2019;132(2):615–23.

    Article  PubMed  Google Scholar 

  46. Güngör A, Baydin S, Middlebrooks EH, Tanriover N, Isler C, Rhoton AL Jr. The white matter tracts of the cerebrum in ventricular surgery and hydrocephalus. J Neurosurg. 2017;126(3):945–71.

    Article  PubMed  Google Scholar 

  47. Gu X, Dubol M, Stiernman L, Wikström J, Hahn A, Lanzenberger R, et al. White matter microstructure and volume correlates of premenstrual dysphoric disorder. J Psychiatry Neurosci. 2022;47(1):E67–e76.

    Article  PubMed  Google Scholar 

  48. Lin YH, Young IM, Conner AK, Glenn CA, Chakraborty AR, Nix CE, et al. Anatomy and white matter connections of the inferior temporal gyrus. World Neurosurg. 2020;143:e656–66.

    Article  PubMed  Google Scholar 

  49. Whitlock KE, Palominos MF. The olfactory tract: basis for future evolution in response to rapidly changing ecological niches. Front Neuroanat. 2022;16:831602.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Carli G, Farabollini F. Neural circuits of fear and defensive behavior. Prog Brain Res. 2022;271(1):51–69.

    Article  PubMed  Google Scholar 

  51. Tuladhar AM, van Norden AG, de Laat KF, Zwiers MP, van Dijk EJ, Norris DG, et al. White matter integrity in small vessel disease is related to cognition. NeuroImage Clin. 2015;7:518–24.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Loubinoux I, Kronenberg G, Endres M, Schumann-Bard P, Freret T, Filipkowski RK, et al. Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med. 2012;16(9):1961–9.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Wang Q, Jie W, Liu JH, Yang JM, Gao TM. An astroglial basis of major depressive disorder? An overview. Glia. 2017;65(8):1227–50.

    Article  PubMed  Google Scholar 

  54. Jha MK, Lee WH, Suk K. Functional polarization of neuroglia: implications in neuroinflammation and neurological disorders. Biochem Pharmacol. 2016;103:1–16.

    Article  CAS  PubMed  Google Scholar 

Download references


The authors thank all participants for their support.


Funding of the study was provided by the National Key Research and development Plan “New Strategy on Pathogenesis and Clinical Diagnosis and Treatment of Chronic Cerebral Small Vessels” (No. 2016YFC1300600) and Tianjin Key Medical Discipline (Specialty) Construction Project.

Author information

Authors and Affiliations



YG and XL designed the study, WF, PZ, XT and YD helped screen and included subjects, YG, YY, XW and DG collected and built the database, YG and XW processed the analysis data, YG and PZ wrote the manuscript, XL and XX reviewed and revised manuscript and all authors read and approved the final version of the submitted manuscript.

Corresponding author

Correspondence to Xin Li.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the ethics committee of The Second Hospital of Tianjin Medical University. All participants have signed an informed consent form. All methods involving human participants were performed in accordance with the ethical standards of the institutional research committee and the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gu, Y., Zhao, P., Feng, W. et al. Structural brain network measures in elderly patients with cerebral small vessel disease and depressive symptoms. BMC Geriatr 22, 568 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: